Ibet

Betamethasone sodium phosphate, the active ingredient in Ibet, is a corticosteroid presented as an injectable solution for intramuscular or intravenous use. It provides anti‑inflammatory and immunosuppressive effects for acute allergic, respiratory and musculoskeletal conditions. It is marketed in the European Union and is indicated for rapid control of severe inflammation.

GNH USA supplies Ibet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Betamethasone sodium phosphate is used as a glucocorticoid to manage acute inflammatory and immune‑mediated conditions.

- Severe allergic reactions: rapid reduction of airway edema, hives and systemic inflammation. - Acute asthma exacerbations: swift bronchodilation and suppression of airway inflammatory cells. - Rheumatic musculoskeletal inflammation: inhibition of cytokine release to relieve joint swelling and pain. - Post‑operative edema: control of fluid accumulation and tissue inflammation after surgery.

Betamethasone sodium phosphate may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels, especially in diabetic patients. - Fluid retention: swelling of extremities and weight gain. - Mood changes: irritability, insomnia or euphoria.

Serious or Rare Side Effects: - Adrenal suppression: reduced endogenous cortisol production. - Severe infection: increased susceptibility to bacterial, viral or fungal pathogens. - Osteonecrosis: bone tissue death, particularly in weight‑bearing joints. - Psychosis: hallucinations, severe mood disturbances or delirium.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for complications. - Infection risk: assess for active infections and avoid use in uncontrolled sepsis. - Blood glucose: monitor diabetic patients closely for hyperglycaemia. - Blood pressure: watch for hypertension or fluid overload. - Dose tapering: avoid abrupt discontinuation to prevent adrenal crisis. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Betamethasone sodium phosphate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Systemic CYP3A4 inhibitors: may increase glucocorticoid exposure. - Live vaccines: risk of attenuated pathogen replication. - Anticoagulants: enhanced bleeding tendency.

Moderate Interactions (Monitor Closely): - Diuretics: potential potassium loss and electrolyte imbalance. - Antidiabetic agents: may require dose adjustment due to altered glucose control. - NSAIDs: increased risk of gastrointestinal ulceration and bleeding.